Shih-Ting Chiu, PA
Physician Assistant · Richmond
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 2 carriers
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Looking this up.
Plans that list them
4 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Shih-Ting Chiu’s office at (510) 307-1500 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
4 of 4 plans
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
Original Medicare doctor bills
$3,644,956
Medicare paid this office $3,644,956 for 13 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Skin biopsy | 1-10 | None |
Who their Medicare patients are
13 Original Medicare patients in 2024. Average age 78 · Health risk score 1.34. Above the middle of the specialty; the typical physician assistant clinician is at 1.31.
The office billed $5,574,691, Medicare allowed $4,574,817 and paid $3,644,956; for 2,575 services of 19 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 13 | 2,575 | 78 | 1.34 | $5,574,691 | $3,644,956 |
| 2023 | 467 | 2,915 | 75 | 1.07 | $420,714 | $109,458 |
| 2022 | 688 | 4,498 | 74 | 1.04 | $685,272 | $174,314 |
| 2021 | 244 | 928 | 74 | 0.96 | $137,861 | $44,298 |
| 2020 | 260 | 1,880 | 73 | 1.02 | $198,954 | $75,595 |
| 2019 | 132 | 377 | 74 | 0.99 | $51,588 | $20,065 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 14 services
| Short return visit (20+ min) | 343 | $28,320 | $56 |
| Destruction of skin growth, 1-14 growths | 159 | $17,488 | $81 |
| Destruction of precancer skin growth, 15 or more growths | 70 | $11,298 | $130 |
| Biopsy of related skin growth, first growth | 161 | $10,829 | $60 |
| Destruction of precancer skin growth, 1 growth | 206 | $9,349 | $33 |
| Destruction of precancer skin growth, 2-14 growths | 179 | $5,928 | $5 |
| New patient visit (30+ min) | 78 | $5,575 | $71 |
| Destruction of skin growth, 15 or more growths | 33 | $5,066 | $103 |
| Return visit (30+ min) | 47 | $4,478 | $79 |
| Short return visit | 66 | $3,160 | $37 |
| Biopsy of related skin growth, each additional growth | 41 | $2,364 | $38 |
| Injection into skin growth, more than 7 growths | 12 | $1,409 | $45 |
| Injection into skin growth, 1-7 growths | 12 | $537 | $30 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 22 | $37 | None |
2022: 16 services
| Short return visit (20+ min) | 448 | $36,715 | $56 |
| Destruction of skin growth, 1-14 growths | 226 | $29,754 | $81 |
| Biopsy of related skin growth, first growth | 261 | $20,987 | $64 |
| Destruction of precancer skin growth, 1 growth | 301 | $14,457 | $32 |
| Destruction of precancer skin growth, 15 or more growths | 72 | $11,938 | $119 |
| New patient visit (30+ min) | 165 | $10,169 | $62 |
| Destruction of precancer skin growth, 2-14 growths | 254 | $8,459 | $5 |
| Return visit (30+ min) | 74 | $7,248 | $75 |
| Destruction of skin growth, 15 or more growths | 46 | $6,964 | $94 |
| Short return visit | 116 | $5,813 | $40 |
| Biopsy of related skin growth, each additional growth | 83 | $5,432 | $39 |
| New patient visit (45+ min) | 28 | $2,778 | $99 |
| Injection into skin growth, 1-7 growths | 27 | $1,981 | $35 |
| Biopsy of ear | 23 | $1,398 | $50 |
| New patient visit (15+ min) | 13 | $533 | $41 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 27 | $38 | None |
2021: 10 services
| Short return visit (20+ min) | 106 | $8,618 | $64 |
| Destruction of skin growth, 1-14 growths | 67 | $7,156 | $82 |
| Biopsy of related skin growth, first growth | 69 | $4,811 | $67 |
| Destruction of precancer skin growth, 1 growth | 68 | $3,344 | $42 |
| New patient visit (30+ min) | 44 | $2,917 | $66 |
| Destruction of precancer skin growth, 15 or more growths | 15 | $2,309 | $136 |
| Return visit (30+ min) | 13 | $1,362 | $97 |
| Destruction of precancer skin growth, 2-14 growths | 60 | $1,356 | $5 |
| Biopsy of related skin growth, each additional growth | 21 | $1,072 | $43 |
| Short return visit | 19 | $820 | $43 |
2020: 9 services
| Destruction of precancer skin growth, 1 growth | 152 | $12,491 | $42 |
| Destruction of skin growth, 1-14 growths | 83 | $10,883 | $86 |
| Short return visit (20+ min) | 112 | $9,223 | $52 |
| Biopsy of related skin growth, first growth | 91 | $8,419 | $70 |
| Destruction of precancer skin growth, 2-14 growths | 148 | $4,165 | $5 |
| New patient visit (30+ min) | 48 | $3,037 | $63 |
| Biopsy of related skin growth, each additional growth | 29 | $1,689 | $46 |
| Short return visit | 32 | $1,118 | $31 |
| Destruction of skin growth, 15 or more growths | 11 | $962 | $74 |
2019: 9 services
| Short return visit (20+ min) | 45 | $3,063 | $58 |
| Destruction of skin growth, 1-14 growths | 29 | $2,835 | $89 |
| Destruction of precancer skin growth, 15 or more growths | 19 | $2,650 | $126 |
| Biopsy of related skin growth, first growth | 28 | $1,942 | $67 |
| Destruction of skin growth, 15 or more growths | 13 | $1,576 | $105 |
| New patient visit (30+ min) | 17 | $1,291 | $76 |
| Destruction of precancer skin growth, 1 growth | 33 | $1,289 | $35 |
| Short return visit | 13 | $469 | $36 |
| Destruction of precancer skin growth, 2-14 growths | 25 | $458 | $5 |
Medicaid work
$7,240 in 2024
Medicaid paid $7,240 for 40 billed services this clinician did in 2024, up to 14 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 40 | $7,240 |
| 2024 | 40 | 1 | 14 | $7,240 |
Drugs they prescribed that Part D paid
$383,260
Pharmacies billed $383,260 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,133) in 2024. At or below the middle of the specialty; the typical physician assistant clinician is at 1%.
977 generic and 156 brand-name prescriptions · $383,260 in drug cost · 81 antibiotic prescriptions to 58 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Otezla | 35 | $155,548 | $4,444 |
| Cosentyx Sensoready (2 Pens) | 11 | $73,181 | $6,653 |
| Dupixent | 12 | $43,847 | $3,654 |
| Amjevita(Cf) | 12 | $12,230 | $1,019 |
| Tacrolimus | 49 | $5,838 | $119 |
See all 23 drugs
| Otezla | 35 | $155,548 | $4,444 |
| Cosentyx Sensoready (2 Pens) | 11 | $73,181 | $6,653 |
| Dupixent | 12 | $43,847 | $3,654 |
| Amjevita(Cf) | 12 | $12,230 | $1,019 |
| Tacrolimus | 49 | $5,838 | $119 |
| Fluocinolone Acetonide | 79 | $5,499 | $70 |
| Fluorouracil | 126 | $4,736 | $38 |
| Clobetasol Propionate | 114 | $2,906 | $25 |
| Calcipotriene | 33 | $2,609 | $79 |
| Ketoconazole | 96 | $2,125 | $22 |
| Mupirocin | 85 | $1,143 | $13 |
| Hydrocortisone | 56 | $962 | $17 |
| Doxycycline Monohydrate | 44 | $961 | $22 |
| Betamethasone Diprop Augmented | 21 | $920 | $44 |
| Clindamycin Phosphate | 33 | $855 | $26 |
| Triamcinolone Acetonide | 66 | $831 | $13 |
| Alclometasone Dipropionate | 11 | $830 | $75 |
| Metronidazole | 31 | $602 | $19 |
| Retin-A | 23 | $491 | $21 |
| Fluocinonide | 23 | $446 | $19 |
| Fluocinolone Acetonide | 12 | $352 | $29 |
| Cephalexin | 32 | $259 | $8 |
| Hydroxyzine | 21 | $134 | $6 |
Year by year
| 2024 | 1,133 | 467 | 0% (0) | 14% | $383,260 |
| 2023 | 705 | 301 | 0% (0) | None | $195,291 |
| 2022 | 852 | 381 | 0% (0) | None | $169,305 |
| 2021 | 311 | 139 | 0% (0) | 14% | $133,490 |
| 2020 | 523 | 171 | 0% (0) | 15% | $136,236 |
| 2019 | 357 | 153 | None | 13% | $32,392 |
| 2018 | 31 | 21 | 0% (0) | None | $2,161 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 17 drugs
| Dupixent | 15 | $56,013 | $3,734 |
| Clobetasol Propionate | 97 | $6,303 | $65 |
| Ketoconazole | 114 | $3,003 | $26 |
| Betamethasone Diprop Augmented | 34 | $2,410 | $71 |
| Metronidazole | 18 | $1,642 | $91 |
| Calcipotriene | 12 | $1,183 | $99 |
| Fluorouracil | 22 | $1,074 | $49 |
| Mupirocin | 78 | $931 | $12 |
| Doxycycline Hyclate | 25 | $723 | $29 |
| Ciclopirox | 12 | $612 | $51 |
| Betamethasone Dipropionate | 14 | $493 | $35 |
| Triamcinolone Acetonide | 36 | $413 | $11 |
| Hydrocortisone | 44 | $394 | $9 |
| Clindamycin Phosphate | 11 | $321 | $29 |
| Mometasone Furoate | 13 | $276 | $21 |
| Hydroxyzine | 13 | $214 | $16 |
| Cephalexin | 21 | $114 | $5 |
2022: 17 drugs
| Dupixent | 13 | $44,583 | $3,429 |
| Jublia | 12 | $16,163 | $1,347 |
| Ketoconazole | 99 | $4,590 | $46 |
| Betamethasone Diprop Augmented | 64 | $4,394 | $69 |
| Clobetasol Propionate | 76 | $3,775 | $50 |
| Metronidazole | 43 | $3,528 | $82 |
| Fluorouracil | 19 | $1,845 | $97 |
| Betamethasone Dipropionate | 29 | $1,384 | $48 |
| Mometasone Furoate | 57 | $1,263 | $22 |
| Clindamycin Phosphate | 12 | $855 | $71 |
| Mupirocin | 75 | $807 | $11 |
| Doxycycline Hyclate | 26 | $727 | $28 |
| Triamcinolone Acetonide | 72 | $574 | $8 |
| Ciclopirox | 16 | $424 | $26 |
| Hydrocortisone | 46 | $319 | $7 |
| Cephalexin | 21 | $183 | $9 |
| Hydroxyzine | 20 | $95 | $5 |
2021: 13 drugs
| Otezla | 24 | $101,626 | $4,234 |
| Ketoconazole | 25 | $1,853 | $74 |
| Betamethasone Diprop Augmented | 17 | $1,284 | $76 |
| Metronidazole | 15 | $1,168 | $78 |
| Doxycycline Hyclate | 26 | $1,031 | $40 |
| Clobetasol Propionate | 15 | $863 | $58 |
| Mometasone Furoate | 27 | $668 | $25 |
| Clindamycin Phosphate | 12 | $590 | $49 |
| Betamethasone Dipropionate | 12 | $554 | $46 |
| Fluticasone Propionate | 15 | $514 | $34 |
| Mupirocin | 18 | $204 | $11 |
| Ciclopirox | 11 | $204 | $19 |
| Triamcinolone Acetonide | 14 | $120 | $9 |
2020: 19 drugs
| Otezla | 19 | $70,780 | $3,725 |
| Clobetasol Propionate | 23 | $2,129 | $93 |
| Ketoconazole | 40 | $2,041 | $51 |
| Fluocinonide | 27 | $2,021 | $75 |
| Halobetasol Propionate | 15 | $1,904 | $127 |
| Doxycycline Hyclate | 28 | $1,627 | $58 |
| Betamethasone Diprop Augmented | 12 | $1,454 | $121 |
| Fluticasone Propionate | 48 | $1,182 | $25 |
| Fluorouracil | 11 | $1,154 | $105 |
| Metronidazole | 19 | $1,152 | $61 |
| Clindamycin Phosphate | 15 | $1,132 | $75 |
| Betamethasone Dipropionate | 18 | $971 | $54 |
| Mometasone Furoate | 28 | $575 | $21 |
| Econazole Nitrate | 11 | $490 | $45 |
| Triamcinolone Acetonide | 34 | $469 | $14 |
| Hydroxyzine | 26 | $261 | $10 |
| Mupirocin | 37 | $249 | $7 |
| Hydrocortisone | 19 | $238 | $13 |
| Cephalexin | 17 | $60 | $4 |
2019: 11 drugs
| Betamethasone Diprop Augmented | 19 | $4,922 | $259 |
| Betamethasone Dipropionate | 25 | $1,913 | $77 |
| Clobetasol Propionate | 14 | $1,395 | $100 |
| Ketoconazole | 24 | $1,273 | $53 |
| Fluocinonide | 16 | $1,040 | $65 |
| Mometasone Furoate | 21 | $598 | $28 |
| Fluticasone Propionate | 21 | $565 | $27 |
| Mupirocin | 54 | $458 | $8 |
| Triamcinolone Acetonide | 20 | $421 | $21 |
| Cephalexin | 25 | $273 | $11 |
| Hydroxyzine | 14 | $71 | $5 |
Money from drug and device companies
$46 in 2025
| 2025 | 1 | 1 | None | $46 |
| 2024 | 5 | 7 | None | $780 |
| 2023 | 15 | 96 | $1,166 | $4,041 |
| 2022 | 17 | 96 | $119 | $2,841 |
| 2021 | 17 | 63 | $19 | $1,996 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| LEO Pharma | Adbry | $46 | 1 payment
|
See the published payment
| LEO Pharma | Meals · 2025-10-11 | Adbry | $46 |
See earlier years (2024, 2023, 2022, 2021)
2024: $780
| LEO Pharma | Adbry | $265 | 2 payments
|
| Janssen Biotech | Tremfya | $150 | 1 payment
|
| Genzyme | Dupixent | $138 | 2 payments
|
| Abbvie | Skyrizi | $125 | 1 payment
|
| Dermavant Sciences | Vtama | $102 | 1 payment
|
2023: $4,041
| Regeneron Healthcare Solutions | Dupixent | $1,387 | 13 payments
|
| Abbvie | Skyrizi | $540 | 18 payments
|
| Janssen Biotech | Tremfya | $388 | 9 payments
|
| Genzyme | Dupixent | $357 | 9 payments
|
| Pfizer | Eucrisa | $267 | 9 payments
|
| Dermavant Sciences | Vtama | $223 | 11 payments
|
| Incyte | Opzelura | $192 | 5 payments
|
| LEO Pharma | Adbry | $182 | 4 payments
|
| Arcutis Biotherapeutics | None | $95 | 3 payments
|
| Journey Medical | None | $93 | 2 payments
|
| Lilly USA | Taltz | $93 | 4 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $71 | 4 payments
|
| Novartis Pharmaceuticals | Cosentyx | $66 | 2 payments
|
| STRATA Skin Sciences | Xtrac | $46 | 2 payments
|
| Sun Pharmaceutical Industries | Winlevi | $42 | 1 payment
|
2022: $2,841
| Abbvie | Skyrizi | $630 | 30 payments
|
| Incyte | Opzelura | $329 | 8 payments
|
| Journey Medical | Qbrexza | $313 | 9 payments
|
| Regeneron Healthcare Solutions | Dupixent | $312 | 12 payments
|
| Genzyme | Dupixent | $247 | 9 payments
|
| Pfizer | Eucrisa | $171 | 7 payments
|
| Allergan | Botox | $156 | 2 payments
|
| LEO Pharma | Adbry | $148 | 4 payments
|
| EPI Health | Wynzora | $132 | 2 payments
|
| Janssen Scientific Affairs | Tremfya | $125 | 1 payment
|
| Galderma Laboratories L.P. | Epsolay | $67 | 3 payments
|
| Sun Pharmaceutical Industries | Ilumya | $52 | 2 payments
|
| Janssen Biotech | Remicade | $50 | 2 payments
|
| Genentech USA | Erivedge | $49 | 2 payments
|
| Novartis Pharmaceuticals | Cosentyx | $22 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $20 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Spevigo | $18 | 1 payment
|
2021: $1,996
| Regeneron Healthcare Solutions | Dupixent | $366 | 7 payments
|
| AbbVie | Skyrizi | $295 | 11 payments
|
| Galderma Laboratories L.P. | Aklief | $195 | 5 payments
|
| VYNE Pharmaceuticals | Amzeeq | $157 | 3 payments
|
| Incyte | Opzelura | $156 | 2 payments
|
| Janssen Scientific Affairs | Tremfya | $132 | 2 payments
|
| Sun Pharmaceutical Industries | Absorica Ld | $129 | 7 payments
|
| Janssen Biotech | Tremfya | $117 | 5 payments
|
| Pfizer | Eucrisa | $108 | 3 payments
|
| LEO Pharma | Finacea | $70 | 4 payments
|
| Mayne Pharma | None | $63 | 3 payments
|
| Sanofi-Aventis U.S. | Dupixent | $60 | 3 payments
|
| Genzyme | Dupixent | $53 | 3 payments
|
| Lilly USA | Taltz | $29 | 2 payments
|
| Genentech USA | Erivedge | $25 | 1 payment
|
| Almirall | Seysara | $23 | 1 payment
|
| Dermira | Qbrexza | $18 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 98.3 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1164758108
- Licence
- CA PA55529, CA AC13289
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Physician assistant, surgical (363AS0400X); Federal specialty code 171100000X (171100000X); Physician assistant (363A00000X)
- Mailing address
- 6644 Mount Wellington Dr, San Jose, CA, 95120
- NPI first listed
- 2009-10-27
- NPI last updated
- 2023-01-23
- NPI record certified
- 2023-01-23
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 5699 Milgrove Way, Chino Hills, CA, 91709 · 9460 N Name Uno Ste 210, Gilroy, CA, 95020